5/2/2022 8:34:06 AM
Gilead And Dragonfly Announce Strategic Research Collaboration
4/28/2022 4:29:05 PM
Gilead Sciences Q1 EPS $0.02 Vs. $1.37 Year Ago
4/19/2022 8:08:00 AM
Kite: FDA Approves Commercial Production At New CAR T-cell Therapy Manufacturing Facility In Frederick, Maryland
3/28/2022 11:10:18 AM
Gilead Sciences Announces $24 Mln In Grants To Help End HIV Epidemic
3/7/2022 8:33:27 AM
Gilead Sciences : Phase 3 Study Meets Primary Endpoint Of PFS In Late-Line HR+/HER2- Metastatic Breast Cancer
3/1/2022 8:36:27 AM
Gilead Gets Complete Response Letter From FDA For Investigational Lenacapavir Due To Vial Compatability Issues
2/11/2022 8:07:27 AM
Gilead Says Remdesivir Retains Antiviral Activity Against Omicron, Delta And Other SARS-CoV-2 Variants In Studies
2/1/2022 4:40:36 PM
Gilead Sciences Q4 EPS $0.30 Vs. $1.23 Year Ago
2/1/2022 4:26:29 PM
Gilead Sciences Inc. (GILD) Declares $ 0.73 Dividend for Q1 22, Record Date 3/15/2022